#WeightLoss #DiabetesTreatment #GLP1
nypost.com
People dropped out of Eli Lilly's new GLP-1 drug trial because they...
Participants taking the highest dose of Eli Lilly's new GLP-1 drug lost an average of 28. 7% of their body weight in a late-stage trial, putting it on track to be a heavyweight in the crowded world of weight-loss and diabetes treatments.
#Diabetes #VisionHealth #Metformin
www.foxnews.com
Common diabetes drug may help preserve eyesight as people age
A common medication for diabetes may slow down age-related vision loss, according to new research.
People with diabetes who were over the age of 55 and taking metformin -- a prescription drug most commonly used to treat type 2 diabetes -- were 37% less likely to develop intermediate age-related macular degeneration (AMD) over five years compared to those not taking it.
#Diabetes #Hypertension #CardiovascularHealth
www.medscape.com
Early Hypertension Linked to a Poorer Prognosis in T2D
In patients with type 2 diabetes (T2D), both young-onset hypertension (onset before the age of 45 years) and late-onset hypertension (onset at the age of 45 years or later) were associated with higher risks for cardiovascular disease (CVD), congestive heart failure, chronic kidney disease, and all-cause mortality, with young-onset hypertension linked to poorer outcomes.
#Diabetes #HeartHealth #CardiovascularDisease
www.socialnews.xyz
Type 2 diabetes quietly rewires heart, raises risk of failures: Study
New Delhi, Jan 5 (SocialNews. XYZ) Type 2 diabetes quietly changes the heart structure and how it produces energy, thus increasing the risk of heart failure, according to a study.
A
#Diabetes #Type1Diabetes #AthleteLife
www.atptour.com
How Patrick Zahraj is acing diabetes: 'There is always a way'
How Patrick Zahraj is acing diabetes: 'There is always a way'
I was nine years old when my life changed forever.
I had a virus for a couple of weeks when I began drinking a lot of water, which was my body's attempt to get excess sugar out of my bloodstream.
S
#Diabetes #Insulin #HealthCare
scitechdaily.com
One of the Most Common Diabetes Treatments May Be Making the Disease Worse, Study Warns
A new study suggests that one of the most common diabetes treatments may speed type 2 diabetes progression by causing insulin-producing cells to lose their functional identity.
